Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00089882 · ClinicalTrials.gov registry record
Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II
A clinical trial, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- 360
- Enrollment target
NCT00089882 is a clinical trial that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 360 participants.
The verdict
NCT00089882 has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- 360 participants
- Enrollment target
Study Summary
The REVEAL II study provides healthy adult children and siblings of Alzheimer's disease patients with genetic testing and information about their own chances of developing the disease. The study will compare a condensed education and counseling program to the current more extensive program.
Interventions
- PROCEDURE APOE Genetic susceptibility testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2003-05 |
| Est. Completion | 2006-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00089882
The ClinicalTrials.gov registry entry for NCT00089882 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which APOE Genetic susceptibility testing is the first listed.
NCT00089882 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00089882 about?
NCT00089882 is a clinical study titled "Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II". The REVEAL II study provides healthy adult children and siblings of Alzheimer's disease patients with genetic testing and information about their own chances of developing the disease. The study will compare a condensed education and counseling program to the current more extensive program.
What is the current status of trial NCT00089882?
This trial is currently completed. The enrollment target is 360 participants. The study started on 2003-05. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00089882?
The interventions under investigation include: APOE Genetic susceptibility testing (PROCEDURE).
Who is sponsoring clinical trial NCT00089882?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.